BOSULIF

About this medicine

Originator: BOSULIF by PF PRISM CV · Manufacturer: GLAXOSMITHKLINE Pharma. Indication & Dosage: BOSULIF (BOSUTINIB MONOHYDRATE), is a prescription medicine used to treat certain types of blood cancer (chronic myelogenous leukemia-CML). BOSUTINIB MONOHYDRATE also works for adult patients with Newly-diagnosed chronic phase Ph+ chronic myelogenous leukemia (CML). BOSULIF is Manufactured by GlaxoSmithKline Pharma Ltd. in Germany. BOSUTINIB MONOHYDRATE has to take orally once daily. Side Effects: The most common adverse reactions of BOSUTINIB MONOHYDRATE are: Nausea , vomiting , stomach / abdominal pain , loss of appetite, cough, joint pain, headache, or dizziness. The above information comes from the Internet. Please consult with doctor for medical advice.

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.